This bill reauthorizes funding for the C.W. Bill Young Cell Transplantation Program, setting $31 million for fiscal year 2025 and $33 million annually for fiscal years 2027-2031. It also extends the deadline for the national cord blood inventory program from 2026 to 2031. The legislation directly affects stem cell research programs and cord blood banks by maintaining federal funding levels and prolonging the inventory program’s timeline. These provisions ensure continuity for existing research infrastructure and blood bank operations without introducing new policy changes.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
HR 2306 extends the Adams Memorial Commission's authority until 2032 and authorizes $50 million in federal funds for the memorial, requiring a 1:1 non-federal match and limiting administrative costs to 4% of federal funds. It updates location rules to allow the memorial within a designated area mapped by the Commission. The bill primarily affects the Adams Memorial Commission and entities contributing to the memorial's funding. It makes no new policy changes but adjusts procedural timelines and funding requirements for an existing commemorative project.
HR 2001 increases annual funding for a grant program supporting dental workforce development from $13.9 million to $15 million, extending the program through fiscal years 2026-2030 (previously 2019-2023) under the Public Health Service Act. The bill modifies existing funding levels to maintain support for addressing dental workforce shortages, with funds remaining available until expended. This change directly affects the operation of the grant program and its ability to fund dental workforce initiatives.
The Stop PRC Economic Espionage Act of 2026 amends federal law to expand the definition of foreign instrumentality. This change allows the U.S. government to classify any entity domiciled in a covered nation, such as China, as a foreign instrumentality even if it is not directly owned or controlled by that government. The bill directly affects companies and organizations operating in these countries by subjecting them to stricter scrutiny under existing economic espionage laws. By broadening who can be considered a foreign agent, the legislation aims to close a loophole that previously required proof of direct government control to trigger certain legal restrictions.
The CANADA FIRE Act authorizes the President to impose targeted economic and diplomatic sanctions on Canada if wildfire smoke from Canadian territory causes significant air quality violations in the United States and the Canadian government is found to have failed to take reasonable mitigation measures. Key provisions include blocking the U.S. assets of specific Canadian officials deemed responsible for these events, revoking their visas, and prohibiting new U.S. government contracts or financial transactions with the Canadian government. The bill also directs Congress to consider declaring Canadian diplomatic personnel persona non grata as a further measure of pressure. Sanctions would remain in effect until the President certifies that Canada has implemented credible wildfire prevention plans and that no significant smoke events have occurred for a specified period, with exceptions carved out for humanitarian aid and emergency response.
The IBOGAINE Act aims to accelerate the development and approval of ibogaine and similar compounds for treating addiction, trauma, and serious mental illnesses by modifying federal drug laws. It creates a new voucher system that grants sponsors of breakthrough mental health drugs priority review by the FDA, while also establishing special registration rules to allow physicians to legally administer Schedule I substances to eligible patients under the "right to try" law. The legislation further directs the Department of Veterans Affairs to create a dedicated senior official and workforce plan for emerging therapies, mandates timely rescheduling of ibogaine from Schedule I to Schedule II, and requires federal agencies to share clinical trial data to speed up the approval process.
The Save MEDICARE Act of 2026 aims to improve the Medicare Advantage program by starting in 2028 with several changes to how health plans are paid and monitored. It requires the government to exclude diagnoses from chart reviews when calculating payments to prevent plans from inflating costs based on questionable data. The bill also speeds up audits and appeals to ensure faster resolution of coding disputes and introduces a new penalty system to recover overpayments from plans. Additionally, the law allows states to enforce Medicare rules within their borders and bans financial incentives for doctors based on how they code patient records. Finally, it establishes a mechanism for the Department of Veterans Affairs to recover costs when Medicare Advantage plans cover care that should have been paid for by the VA.
This resolution honors the life and legacy of the late Senator Lindsey Olin Graham from South Carolina. It formally acknowledges his extensive career in the military, state government, and Congress, noting his service as a Senator and his roles as Chairman of the Judiciary and Budget committees. The Senate expresses its sorrow over his death and requests that this tribute be shared with the House of Representatives and Graham's family.
This resolution expresses the House of Representatives' support for maintaining equity, diversity, and inclusion in federally funded health research to improve scientific quality and patient outcomes. It opposes proposed administrative rules that would allow political appointees to override peer reviews, restrict international collaborations, and ban funding for studies on diversity and health disparities. The text highlights historical data showing that excluding women and people of color from research has led to medical gaps, such as inaccurate diagnostic tools for Black patients and delayed diagnoses for women with heart disease. Ultimately, the bill urges the administration to preserve the current science-based peer review system and remove barriers that prevent underserved communities from benefiting from medical advancements.
This bill establishes a comprehensive sanctions framework targeting the Russian government and its affiliated entities in response to ongoing military actions. It authorizes the President to block assets, revoke visas, and prohibit financial transactions for Russian officials, military leaders, and foreign persons supporting Russia's defense industry or undermining Ukraine. The legislation also bans U.S. investments in Russian energy sectors, prohibits the purchase of Russian sovereign debt, and imposes high tariffs on Russian imports while restricting crude oil purchases by specific foreign nations. Additionally, the bill prevents Russian companies from listing on U.S. stock exchanges and includes mechanisms for terminating sanctions only if Russia signs a peace agreement accepted by Ukraine and ceases hostilities.
